share_log

デ・ウエスタン・セラピテクス研究所:緑内障治療剤「H-1337」の米国後期第II相臨床試験における被験者への投与開始のお知らせ

D. Western Therapeutics Institute: Notice of commencement of administration of the glaucoma drug “H-1337” to test subjects in the late US phase II clinical trial

JPX ·  Aug 28, 2023 19:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more